- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PFE
Recent news which mentions PFE
5 Unbeatable Stocks I'm Eager to Buy in 2025
December 30, 2024
From Motley Fool
My 5 Favorite Ultra-High-Yield Dividend Stocks to Buy for 2025
December 30, 2024
From Motley Fool
360 Stocks in the S&P 500 Underperformed the Benchmark's 2024 Gain of 24%. Here's 2 High-Yielding S&P 500 Stocks to Buy in 2025, According to Wall Street.
December 29, 2024
From Motley Fool
Tickers
PFE
From Motley Fool
10 Overlooked Stocks Set to Soar in 2025
December 28, 2024
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
December 26, 2024
From Benzinga
4 Dividend Stocks to Double Up on Right Now
December 25, 2024
From Motley Fool
Better Income Stock: Pfizer or Altria Group?
December 25, 2024
From Motley Fool
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
December 23, 2024
From Benzinga
Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst Conviction
December 23, 2024
From Benzinga
From Motley Fool
Stocking Stuffers for Income Investors: 3 Ultra-High-Yield Dividend Stocks to Buy Before the End of 2024
December 23, 2024
From Motley Fool
Pfizer Just Reassured Investors, but Is the Stock a Buy?
December 22, 2024
Tickers
PFE
From Motley Fool
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
December 22, 2024
From Motley Fool
The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025
December 21, 2024
From Motley Fool
My Top 10 Stocks to Buy for 2025
December 21, 2024
From Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
From Benzinga
Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?
December 19, 2024
Tickers
PFE
From Motley Fool
3 of the Safest Ultra-High-Yield Dividend Stocks to Buy in 2025
December 18, 2024
From Motley Fool
What's Going On With CVS Health, UnitedHealth And Cigna Group Shares?
December 17, 2024
From Benzinga
Stock Of The Day: Is Pfizer About To Break Out? Expect A New Uptrend If Resistance Breaks
December 17, 2024
Tickers
PFE
From Benzinga
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
December 17, 2024
From Benzinga
Pfizer Does Not Anticipate Material Changes To US Vaccine Policy From The Incoming Administration In 2025
December 17, 2024
From Benzinga
From Motley Fool
From Benzinga
Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030
December 16, 2024
From Motley Fool
Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children
December 13, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.